Greenwich LifeSciences Inc (GLSI)
14.07
-0.38
(-2.63%)
USD |
NASDAQ |
May 17, 16:00
14.07
0.00 (0.00%)
After-Hours: 20:00
Greenwich LifeSciences Total Assets (Quarterly): 6.995M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.995M |
| September 30, 2023 | 9.150M |
| June 30, 2023 | 10.95M |
| March 31, 2023 | 11.92M |
| December 31, 2022 | 13.48M |
| September 30, 2022 | 15.65M |
| June 30, 2022 | 17.20M |
| March 31, 2022 | 19.75M |
| Date | Value |
|---|---|
| December 31, 2021 | 27.22M |
| September 30, 2021 | 28.92M |
| June 30, 2021 | 29.82M |
| March 31, 2021 | 30.42M |
| December 31, 2020 | 28.68M |
| September 30, 2020 | 6.274M |
| June 30, 2020 | 0.2807M |
| December 31, 2019 | 0.0267M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0267M
Minimum
Dec 2019
30.42M
Maximum
Mar 2021
16.05M
Average
14.56M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 63.94B |
| Outlook Therapeutics Inc | 59.03M |
| Gain Therapeutics Inc | 14.58M |
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.2944M |
| Shareholders Equity (Quarterly) | 6.700M |